does medical cover glp 1 for weight loss in california Medicaid Coverage of and Spending on GLP-1s GLP-1 Therapy Insurance Approval |

Discover why some women are turning to Ozempic, a drug primarily prescribed for managing type 2 diabetes, to combat weight gain during menopause

Yeast infections are a reported side effect in some people taking semaglutide and other GLP-1 receptor agonists

Factors such as side effects, high out-of-pocket costs, injection fatigue and stigma around obesity treatment drive troves of patients some studies estimate roughly half or more to stop GLP-1s within a year and risk regaining the weight they lost

Fueled by record demand for Ozempic, Wegovy, and Mounjaro, the companys parent, Sigma Healthcare, reported a 17% rise in sales for the first quarter of fiscal 2026

This overview explains what middle back pain is, why it happens, how it is diagnosed and treated, and when to seek helpsupported by key statistics so patients understand their risks and options.

Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.